MK-0359 25mg 25mg | Purity Not Available
Adooq Bioscience
MK-0359 is a selective and potent oral PDE4 inhibitor, in chronic asthma.
More Information Supplier PageMK-0359 is a selective and potent oral PDE4 inhibitor, in chronic asthma.
More Information Supplier PageMK-0359 is a selective and potent oral PDE4 inhibitor, in chronic asthma.
More Information Supplier PageSKLB610 is a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
More Information Supplier PageSKLB610 is a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
More Information Supplier PageSKLB610 is a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
More Information Supplier PageShows antimalerial activity with IC50 values of 11.2 nM for 3D7 strain, 12.6 nM for HB3 strain, 17.6 nM for K1 strain
More Information Supplier PageShows antimalerial activity with IC50 values of 11.2 nM for 3D7 strain, 12.6 nM for HB3 strain, 17.6 nM for K1 strain
More Information Supplier Page